Davos Alzheimer's Collaborative’s Post

https://lnkd.in/ddHb8npm We will be attending the Alzheimer's Association® International Conference (AAIC) in Philadelphia from July 28th to August 1st! We'll have Brittany Weddington, Director of Business Development; Dani Cabral, MD, Principal Investigator of our Phoenix site; Mireya Medina, Site Director of our Albuquerque site there to discuss the latest research and learn more about our work in Alzheimer's disease. Set up a meeting today! #AAIC2024 #AlzheimersResearch #DementiaResearch #ClinicalTrials #AlzheimersandBrainAwarenessMonth

That's a wrap for our Lunch&Learn series 2023! In this final webinar, we delved into Alzheimer's Disease, discussing its multifaceted aspects and the different diagnostic methods available. We would like to thank everyone who joined us and we look forward to having you again. #webinar #alzheimersdisease #lunchandlearn

🌅 The Longest Day: Standing Together Against Alzheimer's 🌅 Today, on the summer solstice, we join thousands around the world in observing #TheLongestDay, a day dedicated to fighting Alzheimer's disease. This powerful event, organized by the Alzheimer's Association®, symbolizes the challenging journey faced by those living with Alzheimer's and their caregivers. At SYNAPS Dx - an Alzheimer's Diagnostic company, we are deeply committed to advancing the understanding, diagnosis, and treatment of Alzheimer's disease. Our team works tirelessly to diagnose patients and provide answers to patients and their families, offering hope and clarity in the face of this relentless condition. On this longest day of the year, let's stand together to honor the strength, heart, and endurance of those affected by Alzheimer's. Whether you're participating in an event, sharing your story, or simply spreading awareness, every action counts. Let's shed light on the darkness of Alzheimer's and work towards a future where this disease is a thing of the past. Together, we can make a difference. 💜 #TheLongestDay #EndAlz #AlzheimersAwareness #SYNAPSDx #DISCERNtest #AlzheimersDiagnostics

We were delighted to introduce InRAD, an international, practice-based registry for Alzheimer's Disease and other dementias at the EADC (European Alzheimer's Disease Consortium) annual meeting yesterday.   One of our founding Board members, Frank Jessen, explained how InRAD can help address pressing questions about the clinical management of Alzheimer's disease, enable large study collaborations with a common minimum data set and facilitate a wide range of sub-studies on a global scale.   Click here to find out more about InRAD and join our effort to accelerate progress in Alzheimer's practice-based research: https://lnkd.in/gGDTvs6i   #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry

As you return to work and cleanout your inboxes to start 2024, considering adding a really meaningful message to your week by signing up for our E-Newsletter below

Payers should be prepared for the wave of patients coming and open up resources to keep them aging in place with a caregiver at home. This is where I’d like to see more innovation and learning. The Alzheimers initiative for payers is a great use case for machine learning and prediction using data made accessible via Patent Access API for operational use cases to inform future management of the Alzheimers wave predicted to spike in 2025 (reported by CNN nearly 5 years ago). The time has come, payers and providers should be prepared and properly reimbursed for serving these vulnerable populations. These patents are excluded from Quality measurement, but the financial burden of not following this population will be huge if organizations don’t get ahead of it now.

New therapies today drive the eradication/attenuation of disease tomorrow 💪 Here at Alcyomics, we feel privelleged to help make this happen 😌🔬 🔈Speak to us today about how our models and assays, including Skimune, can provide research solutions for you! #therapies #immunotoxicology

Registries are powerful tools for conducting observational studies of disease with impact on public health surveillance, research, and intervention, and inform and engage policymakers. Frank Jessen, one of our founding Board members, shared at the EADC (European Alzheimer's Disease Consortium) annual meeting how InRAD may impact clinical management, foster large-scale collaborations, and enable global studies. Join us in accelerating Alzheimer's research!  https://lnkd.in/gGDTvs6i  #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry

💜 November marks Alzheimer's Awareness Month, a time to unite in support of those battling this challenging disease. At AriBio, we're committed to raising awareness, amplifying research efforts, and standing by all those affected. Together, we're driving change towards a future without Alzheimer's. 💜 #alzheimers #alzheimersdisease #alzheimersresearch #alzheimersawarenessmonth #alzheimersawareness

Learn more about what our Alzheimer's Foundation of America chapter is doing through our website. Here, you'll find out what we do, our impact in numbers, our blog publications, and most importantly how to get involved!